• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型二羟萘甲酸抑制剂对恶性疟原乳酸脱氢酶的设计。

Design of novel dihydroxynaphthoic acid inhibitors of Plasmodium falciparum lactate dehydrogenase.

机构信息

University of Abobo Adjamé, Laboratoire de Physique Fondamentale et Appliquée, 02 BP 801, Abidjan 02, Cote D'Ivoire.

出版信息

Med Chem. 2012 Sep;8(5):970-84. doi: 10.2174/157340612802084324.

DOI:10.2174/157340612802084324
PMID:22741776
Abstract

We have studied inhibition of Plasmodium falciparum lactate dehydrogenase (pfLDH) by dihydroxynaphthoic acid (DHNA) analogues derivatives of hemigossypol-sesquiterpene found in cottonseed known to exhibit antimalarial activity. Molecular models of pfLDH-DHNA complexes were prepared from high-resolution crystal structures containing DHNA and azole inhibitors and binding affinities of the inhibitors were computed by molecular mechanics - polarizable continuum model of solvation (MM-PCM) approach. The 3D structures of the pfLDH-DHNA complexes were validated by a QSAR model, which confirmed consistency between the computed binding affinities and experimental inhibition constants for a training set and validation set of twelve DHNA inhibitors obtained from literature. Novel more potent DHNA analogs were identified by structure-based molecular design and predicted to inhibit pfLDH in the low nanomolar concentration range. In addition, the designed DHNA analogs displayed favorable predicted ADME-related profiles and an elevated selectivity for the pfLDH over the human isoform.

摘要

我们研究了二羟萘酸(DHNA)类似物对半乳糖半棉酚-倍半萜(存在于棉籽中,具有抗疟活性)的抑制作用对恶性疟原虫乳酸脱氢酶(pfLDH)的抑制作用。从含有 DHNA 和唑类抑制剂的高分辨率晶体结构中制备了 pfLDH-DHNA 复合物的分子模型,并通过分子力学-极化连续模型的溶剂化(MM-PCM)方法计算了抑制剂的结合亲和力。通过 QSAR 模型验证了 pfLDH-DHNA 复合物的 3D 结构,该模型证实了从文献中获得的十二种 DHNA 抑制剂的训练集和验证集的计算结合亲和力与实验抑制常数之间的一致性。通过基于结构的分子设计鉴定了新型更有效的 DHNA 类似物,并预测它们将以低纳摩尔浓度范围抑制 pfLDH。此外,设计的 DHNA 类似物显示出有利的预测 ADME 相关特征,并且对 pfLDH 的选择性高于人同工酶。

相似文献

1
Design of novel dihydroxynaphthoic acid inhibitors of Plasmodium falciparum lactate dehydrogenase.新型二羟萘甲酸抑制剂对恶性疟原乳酸脱氢酶的设计。
Med Chem. 2012 Sep;8(5):970-84. doi: 10.2174/157340612802084324.
2
Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH).采用高通量虚拟筛选、对接和分子动力学模拟的多电子药效团模型,发现潜在的恶性疟原虫乳酸脱氢酶(PfLDH)抑制剂。
J Biomol Struct Dyn. 2019 Apr;37(7):1783-1799. doi: 10.1080/07391102.2018.1471417. Epub 2018 May 14.
3
Design, synthesis, and biological evaluation of Plasmodium falciparum lactate dehydrogenase inhibitors.恶性疟原虫乳酸脱氢酶抑制剂的设计、合成及生物学评价
J Med Chem. 2007 Aug 9;50(16):3841-50. doi: 10.1021/jm070336k. Epub 2007 Jul 18.
4
Docking studies on the binding of quinoline derivatives and hematin to Plasmodium falciparum lactate dehydrogenase.奎宁衍生物和血红素与恶性疟原虫乳酸脱氢酶结合的对接研究。
J Biomol Struct Dyn. 2011 Aug;29(1):207-18. doi: 10.1080/07391102.2011.10507383.
5
Generation of oxamic acid libraries: antimalarials and inhibitors of Plasmodium falciparum lactate dehydrogenase.草氨酸文库的生成:抗疟药及恶性疟原虫乳酸脱氢酶抑制剂
J Comb Chem. 2007 Mar-Apr;9(2):292-300. doi: 10.1021/cc060110n. Epub 2007 Feb 23.
6
Plasmodium falciparum: stage specific effects of a selective inhibitor of lactate dehydrogenase.恶性疟原虫:乳酸脱氢酶选择性抑制剂的阶段特异性作用
Exp Parasitol. 2005 Oct;111(2):105-14. doi: 10.1016/j.exppara.2005.06.007.
7
Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum.人类乳酸脱氢酶及恶性疟原虫乳酸脱氢酶的选择性抑制剂。
J Med Chem. 1998 Sep 24;41(20):3879-87. doi: 10.1021/jm980334n.
8
Highly potent anti-malarial activity of benzopyrano(4,3-b)benzopyran derivatives and interaction analysis with putative target lactate dehydrogenase.苯并吡喃并[4,3-b]苯并吡喃衍生物具有很强的抗疟活性及与假定靶标乳酸脱氢酶的相互作用分析。
J Biomol Struct Dyn. 2022 Jul;40(11):5159-5174. doi: 10.1080/07391102.2020.1868336. Epub 2021 Jan 8.
9
In-Silico molecular docking and simulation studies on novel chalcone and flavone hybrid derivatives with 1, 2, 3-triazole linkage as vital inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase.基于 1,2,3-三唑键的新型查尔酮和黄酮杂合衍生物作为恶性疟原虫二氢乳清酸脱氢酶关键抑制剂的计算机分子对接和模拟研究。
J Biomol Struct Dyn. 2018 Nov;36(15):3993-4009. doi: 10.1080/07391102.2017.1404935. Epub 2017 Nov 27.
10
Identification and activity of a series of azole-based compounds with lactate dehydrogenase-directed anti-malarial activity.一系列具有乳酸脱氢酶导向抗疟活性的唑类化合物的鉴定及活性研究
J Biol Chem. 2004 Jul 23;279(30):31429-39. doi: 10.1074/jbc.M402433200. Epub 2004 Apr 26.

引用本文的文献

1
Structure, Function, and Thermodynamics of Lactate Dehydrogenases from Humans and the Malaria Parasite .人源和疟原虫乳酸脱氢酶的结构、功能和热力学性质
Biochemistry. 2021 Nov 30;60(47):3582-3595. doi: 10.1021/acs.biochem.1c00470. Epub 2021 Nov 8.
2
In vivo anti-malarial activity of the hydroalcoholic extract of rhizomes of Kniphofia foliosa and its constituents.黄菖蒲根茎水醇提取物及其成分的体内抗疟活性。
Malar J. 2021 Jan 1;20(1):3. doi: 10.1186/s12936-020-03552-7.
3
Structure-Based Design and in Silico Screening of Virtual Combinatorial Library of Benzamides Inhibiting 2-trans Enoyl-Acyl Carrier Protein Reductase of with Favorable Predicted Pharmacokinetic Profiles.
基于结构的设计和虚拟组合文库的计算机筛选苯甲酰胺抑制 2-反式烯酰基辅酶 A 还原酶与有利的预测药代动力学特征。
Int J Mol Sci. 2019 Sep 24;20(19):4730. doi: 10.3390/ijms20194730.
4
Virtual design of novel Plasmodium falciparum cysteine protease falcipain-2 hybrid lactone-chalcone and isatin-chalcone inhibitors probing the S2 active site pocket.新型恶性疟原虫半胱氨酸蛋白酶 falcipain-2 杂合内酯-查尔酮和色胺-查尔酮抑制剂的虚拟设计,探索 S2 活性位点口袋。
J Enzyme Inhib Med Chem. 2019 Dec;34(1):547-561. doi: 10.1080/14756366.2018.1564288.
5
Computer-Aided Design of Orally Bioavailable Pyrrolidine Carboxamide Inhibitors of Enoyl-Acyl Carrier Protein Reductase of Mycobacterium tuberculosis with Favorable Pharmacokinetic Profiles.具有良好药代动力学特征的结核分枝杆菌烯酰-酰基载体蛋白还原酶口服生物可利用吡咯烷甲酰胺抑制剂的计算机辅助设计。
Int J Mol Sci. 2015 Dec 12;16(12):29744-71. doi: 10.3390/ijms161226196.
6
Design of Thymidine Analogues Targeting Thymidilate Kinase of Mycobacterium tuberculosis.靶向结核分枝杆菌胸苷酸激酶的胸苷类似物设计
Tuberc Res Treat. 2013;2013:670836. doi: 10.1155/2013/670836. Epub 2013 Mar 24.